Section Arrow
Quote
VRAX.NASDAQ
- Virax Biolabs Group Limited
Quotes are at least 15-min delayed:2026/08/02 11:05 EDT
Regular Hours
Last
 2.62
-0.18 (-6.43%)
Day High 
2.842 
Prev. Close
2.8 
1-M High
13.19 
Volume 
65.40K 
Bid
2.56
Ask
2.64
Day Low
2.58 
Open
2.78 
1-M Low
2.57 
Market Cap 
2.23M 
Currency 美元 
P/E -- 
%Yield -- 
10-SMA 3.33 
20-SMA 3.57 
50-SMA 4.32 
52-W High 22.4825 
52-W Low 2.5 
Exchange NASDAQ 
Valuation Estimation
EPS (Current/Estimated)
-12.64/-0.24
Enterprise Value
2.54M
Balance Sheet
Book Value Per Share
9.51
Cash Flow
Cash Flow Yield
--
Income Statement
Total Revenue
12.42K
Operating Revenue Per Share
0.01
Industry Comparison
More
Code Name   Last Change Change (%) P/E P/E Range
REPLReplimune Group11.2+5.79+107.02%-- 
GOSSGossamer Bio0.1695-0.0088-4.94%-- 
JUNSJupiter Neurosciences Inc0.09-0.0075-7.69%-- 
KPTIKaryopharm Therapeutics Inc.1.92-5.09-72.61%-- 
IOVAIovance Biotherapeutics4.07-0.62-13.22%-- 
Industry overview quotes are at least 15 minutes delayed (Except Overnight Trading Session)
Business Description
Virax Biolabs Group Ltd is a biotechnology company focused on the detection of immune responses and the development of immune profiling and in vitro diagnostic technologies for viral and immune-mediated diseases, with a current strategic focus on post-acute infection syndromes (PAIS) and related areas of chronic immune dysfunction. The company's principal development activities are centered on T cell-based in vitro diagnostics and immune profiling. The company's flagship product candidate, ViraxImmune, is an in-development T cell-based assay and immune profiling platform intended to support the assessment of immune dysfunction, initially in PAIS indications.
Information provided by: etnet
Terms and Conditions
Bank of China (Hong Kong) Limited
Disclaimer:
This information is provided by ET Net Limited ("ET Net") and/or its third party information providers (the "Sources") and is strictly for reference only. It is not intended to provide any financial or professional advice and any person should not rely upon the same as such. You should obtain relevant and specific professional advice before making any investment decision. Before making an investment decision, you should consider, with the assistance of your professional securities adviser, whether the information is appropriate in light of your particular investment needs, objectives and financial circumstances. ET Net and the Sources endeavor to ensure the accuracy and reliability of the information provided. Notwithstanding the aforesaid, ET Net, the Sources and Bank of China (Hong Kong) Limited do not guarantee or make any representation, warranty or undertaking as to the accuracy, reliability, completeness or timeliness of this information, and accept no responsibility or liability whatsoever (whether in tort or contract or otherwise) for any loss or damage howsoever arising from or in reliance upon the whole or any part of such information.